BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328,570 | -59.1% | 470,137 | -59.3% | 0.02% | -57.4% |
| Q2 2023 | $8,136,290 | -52.0% | 1,155,723 | -43.2% | 0.05% | -54.8% |
| Q1 2023 | $16,966,421 | +0.7% | 2,034,343 | +38.6% | 0.10% | -8.8% |
| Q4 2022 | $16,853,857 | +221.1% | 1,468,106 | +252.5% | 0.11% | +178.0% |
| Q3 2022 | $5,248,000 | +1361.8% | 416,526 | +452.7% | 0.04% | +925.0% |
| Q2 2020 | $359,000 | +897.2% | 75,363 | +316.4% | 0.00% | – |
| Q1 2020 | $36,000 | -99.5% | 18,100 | -99.1% | 0.00% | -100.0% |
| Q4 2019 | $7,302,000 | +56.6% | 2,116,417 | +30.0% | 0.07% | +26.3% |
| Q3 2019 | $4,664,000 | +4178.9% | 1,627,785 | +2212.2% | 0.06% | +2750.0% |
| Q2 2013 | $109,000 | – | 70,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |